Imaging CAR T cell therapy with PSMA-targeted positron emission tomography

Chimeric antigen receptor (CAR) T cell therapy for hematologic malignancies is fraught with several unknowns, including number of functional T cells that engage target tumor, durability and subsequent expansion and contraction of that engagement, and whether toxicity can be managed. Non-invasive, se...

Descripción completa

Detalles Bibliográficos
Autores principales: Minn, Il, Huss, David J., Ahn, Hye-Hyun, Chinn, Tamara M., Park, Andrew, Jones, Jon, Brummet, Mary, Rowe, Steven P., Sysa-Shah, Polina, Du, Yong, Levitsky, Hyam I., Pomper, Martin G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609218/
https://www.ncbi.nlm.nih.gov/pubmed/31281894
http://dx.doi.org/10.1126/sciadv.aaw5096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609218/
https://www.ncbi.nlm.nih.gov/pubmed/31281894
http://dx.doi.org/10.1126/sciadv.aaw5096

Ejemplares similares